First Commonwealth Financial Corp’s AbbVie ABBV Stock Holding History

First Commonwealth Financial Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.6M	Buy	7,344 +613	+9%	+$136K	0.25%	71
2025 Q4	$1.54M	Sell	6,731 -699	-9%	-$159K	0.25%	72
2025 Q3	$1.72M	Sell	7,430 -211	-3%	-$43K	0.29%	58
2025 Q2	$1.42M	Buy	7,641 +82	+1%	+$15.2K	0.31%	57
2025 Q1	$1.58M	Buy	7,559 +352	+5%	+$68.4K	0.37%	53
2024 Q4	$1.28M	Buy	7,207 +167	+2%	+$30.7K	0.3%	59
2024 Q3	$1.39M	Sell	7,040 -32	-0.5%	-$5.97K	0.33%	51
2024 Q2	$1.21M	Buy	7,072 +733	+12%	+$121K	0.31%	56
2024 Q1	$1.15M	Sell	6,339 -597	-9%	-$103K	0.31%	58
2023 Q4	$1.07M	Sell	6,936 -216	-3%	-$31.5K	0.33%	47
2023 Q3	$1.07M	Buy	7,152 +346	+5%	+$50.8K	0.36%	48
2023 Q2	$917K	Buy	6,806 +217	+3%	+$31.8K	0.3%	60
2023 Q1	$1.05M	Sell	6,589 -141	-2%	-$21.6K	0.38%	54
2022 Q4	$1.09M	Buy	6,730 +4,069	+153%	+$624K	0.4%	48
2022 Q3	$357K	Hold	2,661	–	–	0.15%	130
2022 Q2	$408K	Sell	2,661 -499	-16%	-$76.2K	0.15%	130
2022 Q1	$512K	Hold	3,160	–	–	0.16%	116
2021 Q4	$428K	Sell	3,160 -1	-0%	-$118	0.14%	126
2021 Q3	$341K	Sell	3,161 -1	-0%	-$114	0.12%	136
2021 Q2	$357K	Buy	3,162 +350	+12%	+$39.4K	0.13%	134
2021 Q1	$305K	Buy	2,812 +19	+0.7%	+$2.03K	0.12%	138
2020 Q4	$299K	Buy	2,793 +25	+0.9%	+$2.4K	0.13%	136
2020 Q3	$243K	Buy	2,768 +499	+22%	+$47K	0.11%	146
2020 Q2	$223K	Buy	+2,269	New	+$200K	0.11%	152
2019 Q1	–	Sell	-4,727	Closed	-$436K	–	142
2018 Q4	$436K	Hold	4,727	–	–	0.31%	86
2018 Q3	$447K	Buy	4,727 +58	+1%	+$5.5K	0.3%	85
2018 Q2	$433K	Sell	4,669 -208	-4%	-$20.3K	0.45%	71
2018 Q1	$462K	Buy	+4,877	New	+$536K	0.49%	63

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Commonwealth Financial Corp's ABBV Position: Q1 2026 in Review

First Commonwealth Financial Corp increased its AbbVie (ABBV) stake by 9.1% in Q1 2026, buying an estimated $136K and bringing the position to 7,344 shares worth $1.6M. The position accounts for 0.25% of the portfolio, ranked #71.

First Commonwealth Financial Corp first reported a position in ABBV in Q1 2018 and has held it in 28 quarters since. The position peaked at $1.72M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

First Commonwealth Financial Corp held 7,344 shares of AbbVie worth $1.6M as of Q1 2026.
First Commonwealth Financial Corp bought 613 AbbVie shares in Q1 2026, an estimated $136K.
AbbVie made up 0.25% of First Commonwealth Financial Corp's portfolio in Q1 2026, its #71 holding.
First Commonwealth Financial Corp first reported a position in AbbVie in Q1 2018 and has held it in 28 quarters since.
First Commonwealth Financial Corp's AbbVie position peaked at $1.72M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on First Commonwealth Financial Corp's 13F filing for Q1 2026, filed 14 May 2026.